Finance
Markets
No recent trading data. The last price we hold for ABBV is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

ABBV

stock Healthcare Drug Manufacturers - General
AbbVie
$217.13 +1.73 (+0.80%) Delayed · quoted 46d ago
Mixed 42% Steady

What the indicators say

Mixed 3 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
59
0oversold 30overbought 70100

RSI 59 — firm momentum, not yet overbought.

EMA 21 $212.42
Above
Near-term trend is up
SMA 50 $208.81
Above
Medium-term trend is up
SMA 200 $219.75
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $202.37
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $213.72 High $219.54
Open
$217.07
+0.78%
Close
$217.07
+0.78%
52-week range where the price sits across its year
52w low $181.73 52w high $244.81
Current
$217.07
Prev close
$215.40
Volume 0.65× the 3-month average
0 avg 2× avg
Today
4.30M
3-mo avg
6.60M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2983 days ago
Next expected
Jul 30in 9 days

Recent earnings dates

  • Apr 29 83 days ago
  • Apr 3 109 days ago
  • Feb 4 167 days ago
  • Jan 7 195 days ago

Past earnings dates come from ABBV’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Weak

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), ABBV’s fundamentals read as weak overall.

P/E ratio Weak
107.0x

At 107.0x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
3.06%

A 3.1% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
6.9%

A 6.9% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity No data
—

Shareholder equity is negative, so return on equity is not meaningful.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.2%

A 3.2% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak
0.67

At 0.67, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+8.6%

Revenue grew 8.6% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-1.2%

Net income fell 1.2% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $56.2B$58.1B$54.3B$56.3B$61.2B
Net income $11.5B$11.8B$4.9B$4.3B$4.2B
Diluted EPS $6.45$6.63$2.72$2.39$2.36
Dividend / share $1.30$5.71$5.99$6.29$6.65
Total assets $146.5B$138.8B$134.7B$135.2B$134.0B
Total liabilities —————
Shareholder equity $15.4B$17.3B$10.4B$3.3B-$3.3B

Leadershipsynced from SEC 59d ago

  • Michael Robert A. CHAIRMAN OF THE BOARD AND CEO · Director
  • Reents Scott T EVP, CHIEF FINANCIAL OFFICER
  • Crum Demetris D EVP, CHIEF HR OFFICER
  • Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER
  • Purdue David Ryan SVP, Controller
  • Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER
  • Siatis Perry C EVP, GC AND SECRETARY
  • Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER
  • Thakkar Roopal EVP, R&D and CSO
  • Alpern Robert J Director
  • Austin Roxanne S Director
  • Burnside William H.l. Director
  • Davis Jennifer L. Director
  • Falk Thomas J Director
  • Freyman Thomas C Director
  • Hart Brett J Director
  • Meyer Melody B Director
  • Quaggin Susan E Director
  • Rapp Edward J Director
  • Roberts Rebecca B Director
  • Waddell Frederick H Director

Officers and board are drawn from ABBV’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

  • Mar 18 New 6-month low (-15% off peak)
  • Mar 18 −5.2% one-day move
  • Oct 1, 2025 +5.5% one-day move

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$6.56
2026 so far
$3.462 payments
2026 projected
$6.92+5.5% vs 2025

Projection scales ABBV’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Apr 15 $1.73
  • Jan 16 $1.73
  • Oct 15, 2025 $1.64
  • Jul 15, 2025 $1.64
  • Apr 15, 2025 $1.64
  • Jan 15, 2025 $1.64
  • Oct 15, 2024 $1.55
  • Jul 15, 2024 $1.55
  • Apr 12, 2024 $1.55
  • Jan 12, 2024 $1.55
  • Oct 12, 2023 $1.48
  • Jul 13, 2023 $1.48
  • Apr 13, 2023 $1.48
  • Jan 12, 2023 $1.48
  • Oct 13, 2022 $1.41
  • Jul 14, 2022 $1.41
  • Apr 13, 2022 $1.41
  • Jan 13, 2022 $1.41
  • Oct 14, 2021 $1.30
  • Jul 14, 2021 $1.30

Recent SEC filingssynced from SEC 53d ago

© 2026 Isaac Bythewood · Some rights reserved